Dyadic International Inc
NASDAQ:DYAI
Dyadic International Inc
Gross Profit
Dyadic International Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dyadic International Inc
NASDAQ:DYAI
|
Gross Profit
$923k
|
CAGR 3-Years
72%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-19%
|
|
Abbvie Inc
NYSE:ABBV
|
Gross Profit
$36.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Gross Profit
$20.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Gross Profit
$19.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Gross Profit
$8.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Gross Profit
$11.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
See Also
What is Dyadic International Inc's Gross Profit?
Gross Profit
923k
USD
Based on the financial report for Dec 31, 2023, Dyadic International Inc's Gross Profit amounts to 923k USD.
What is Dyadic International Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
-19%
Over the last year, the Gross Profit growth was 14%. The average annual Gross Profit growth rates for Dyadic International Inc have been 72% over the past three years , 28% over the past five years , and -19% over the past ten years .